Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer
Clinical trial NCT03860987 · COMPLETED
Trial details
- NCT number
- NCT03860987
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-30
- Primary completion
- 2026-05-11
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.